An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii

Molecular Microbiology

Volumn 43, Issue 5, 2002, Pages 1309-1318

  Camps, Manel ^a,b   Arrizabalaga, Gustavo ^a   Boothroyd, John ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; MACROLIDE; RIBOSOME DNA; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; APICOPLAST; ARTICLE; CELL ORGANELLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TARGETING; ESCHERICHIA COLI; GENE MUTATION; GENE STRUCTURE; GROWTH DISORDER; MICROBIAL GENETICS; MICROBIAL GROWTH; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RIBOSOME; RNA TRANSLATION; TOXOPLASMA; TOXOPLASMA GONDII; TRANSPEPTIDATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE; MICROSCOPY, ELECTRON; PARASITIC SENSITIVITY TESTS; PLASTIDS; POINT MUTATION; RNA, RIBOSOMAL; TOXOPLASMA;

ESCHERICHIA COLI; PROKARYOTA; PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 0036227773     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2002.02825.x     Document Type: Article

References (43)

1. Gene discovery by EST sequencing in Toxoplasma gondii reveals sequences restricted to the Apicomplexa
2. Free-radical-induced mutation vs. redox regulation: Costs and benefits of genes in organelles
3. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics
4. Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro
5. Chloroplast transformation in Chlamydomonas with high velocity microprojectiles
6. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli
7. Functional interactions within 23S rRNA involving the peptidyltransferase center
8. Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA
9. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23S rRNA peptidyl transferase loop
10. Evidence for functional interaction between domains II and V of 23S ribosomal RNA from an erythromycin-resistant mutant
11. A plastid organelle as a drug target in apicomplexan parasites
12. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii
13. Feedback regulation of rRNA and tRNA synthesis and accumulation of free ribosomes after conditional expression of rRNA genes
14. A plastid segregation defect in the protozoan parasite Toxoplasma gondii
15. Electroporation-stimulated recombination in yeast
16. Sequence analysis of mitochondrial chloramphenicol resistance mutations in Chinese hamster cells
17. Sequence analysis of mouse mitochondrial chloramphenicol-resistant mutants
18. Mitochondrial chloramphenicol-resistant mutants can have deficiencies in energy metabolism
19. Enhanced antiparasitic activity of lipophilic tetracyclines: Role of uptake
20. Mitochondria as the site of action of tetracycline on Plasmodium falciparum
21. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker
22. Nucleo-mitochondrial interactions
23. Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance
24. Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure
25. Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B
26. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA
27. Interaction of antibiotics with functional sites in 16S ribosomal RNA
28. The structural basis of ribosome activity in peptide bond synthesis
29. Interaction of tetracycline with RNA: Photoincorporation into ribosomal RNA of Escherichia coli
30. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin
31. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant
32. Depression ofPlasmodium falciparum dihydroorotate dehydrogenase activity in in vitro culture by tetracycline
33. Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii
34. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: Some additional thoughts
35. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii
36. Microbes as tools for cell biology
37. Microtubules, but not actin filaments, drive cell budding and cell division in Toxoplasma gondii
38. DNA replication and daughter cell budding are not tightly linked in the protozoan parasite Toxoplasma gondii
39. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli
40. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii
41. The importance of highly conserved nucleotides in the binding region of chloramphenicol at the peptidyl transfer centre of Escherichia coli 23S ribosomal RNA
42. Temperature-regulated expression of the tac/lacl system for overproduction of a fungal xylanase in Escherichia coli
43. Delta pH-dependent accumulation of tetracycline in Escherichia coli